Hyo-Soo Kim
Seoul National University Hospital · Seoul University Hospital · Seoul National University Hospital, Department of Internal Medicine
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Hyo-Soo Kim as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 04:29 UTC. Open this list on ClinicalTrials.gov
- Ph4NCT05845489 · Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis- CloPidogREl for Primary preVENTION (HOST-PREVENTION)Seoul National University Hospital · recruiting · Coronary Artery Disease · study chair
- Ph3NCT04858308 · Phase 3 Trial to Evaluate the Efficacy and Safety of YYC506.Yooyoung Pharmaceutical Co., Ltd. · unknown · Dyslipidemias · study chair
- Ph3NCT04158076 · Evaluating the Efficacy and Safety of Co-administrated Rosuvastatin/Ezetimibe and Telmisartan/AmlodipineAddpharma Inc. · completed · Hypercholesterolemia, Hypertension
- Ph3NCT04074551 · A Phase 3 Study to Compare the Efficacy and Safety of Co-administered HGP0608, HGP0904 and HCP1306 Versus HCP1701 in Patients With Hypertension and DyslipidemiaHanmi Pharmaceutical Company Limited · completed · Hypertension, Dyslipidemias · principal investigator
- N/ANCT03903029 · Efficacy of Low-dose (10 mg) Rosuvastatin in Korean 4 Statin Benefit Groups Per 2013 ACC/AHA GuidelineSeoul National University Hospital · completed · Dyslipidemias · study chair
- Ph3NCT03872232 · Evaluating the Efficacy and Safety of Co-administrated Rosuvastatin/Ezetimibe and TelmisartanAddpharma Inc. · completed · Hypercholesterolemia, Hypertension
- Ph4NCT03860220 · The Efficacy and Safety of Triple Therapy of Telmisartan/Amlodipine/RosuvastatinHyo-Soo Kim · completed · Hypertension, Dyslipidemias · principal investigator
- N/ANCT03507205 · Korean Nationwide Multicenter Pooled Registry of Drug-Eluting StentsSeoul National University Hospital · completed · Coronary Artery Disease · study chair
- Ph4NCT03228238 · ANti-Oxidant in Variant Angina (ANOVA) TrialSeoul National University Hospital · terminated · Variant Angina · principal investigator
- N/ANCT03151018 · Effect and Efficacy of Onyx™, Zotarolimus-eluting Stent for Coronary AtherosclerosisSeoul National University Hospital · unknown · Coronary Artery Disease, Acute Coronary Syndrome, Myocardial Infarction · study chair
- N/ANCT02845804 · Effect and Efficacy of Xpedition™/Alpine™, Everolimus-eluting Stent for Coronary AtherosclerosisSeoul National University Hospital · unknown · Coronary Artery Disease, Percutaneous Coronary Intervention, Acute Coronary Syndrome · study chair
- Ph3NCT02749994 · A Clinical Trial to Compare the Efficacy and Safety of a Combination Therapy of Ezetimibe and Rosuvastatin Versus Monotherapy of Rosuvastatin in Hypercholesterolemia Patients (I-ROSETTE Study)IlDong Pharmaceutical Co Ltd · completed · Hypercholesterolemia · principal investigator
- Ph4NCT02601157 · Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis - Coronary Intervention With Next Generation Drug-Eluting Stent Platforms and Abbreviated Dual Antiplatelet Therapy (HOST-IDEA) TrialSeoul National University Hospital · completed · Stable Angina, Unstable Angina, Non-ST Segment Elevation Myocardial Infarction · study chair
- Ph4NCT02410083 · Trial to Assess the Efficacy of Combination Formula of Aspirin Plus Clopidogrel in Patients With Coronary StentJeil Pharmaceutical Co., Ltd. · completed · ANEURYSM CORONARY ARTERY · principal investigator
- Ph4NCT02231788 · The Efficacy of a Combination of Telmisartan/S-Amlodipine Compared With Telmisartan MonotherapyChong Kun Dang Pharmaceutical · completed · Hypertension · principal investigator
- Ph3NCT02205606 · Efficacy/Safety of HCP1306 Tablet Versus HGP0816 Tablet in Patients With Primary HypercholesterolemiaHanmi Pharmaceutical Company Limited · completed · Primary Hypercholesterolemia · principal investigator
- Ph4NCT02193971 · Harmonizing Optimal Strategy for Treatment of Coronary Artery Diseases Trial - Comparison of REDUCTION of PrasugrEl Dose & POLYmer TECHnology in ACS Patients (HOST REDUCE POLYTECH RCT Trial)Seoul National University Hospital · completed · Acute Coronary Syndrome · study chair
- Ph3NCT02166593 · Clinical Trial to Evaluate the Efficacy and Safety of Pravafenix Cap to Verify the Superiority Than AtorvastatinYooyoung Pharmaceutical Co., Ltd. · completed · Combined Dyslipidemia · principal investigator
- Ph4NCT02044250 · Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis- EXtended Antiplatelet Monotherapy (HOST-EXAM)Seoul National University Hospital · completed · Coronary Heart Disease · study chair
- Ph4NCT01605721 · Efficacy and Safety of Xience in Coronary arEry Disease aLL-comers After stENTing Using the PRIME Platform (EXCELLENT-PRIME Registry)Seoul National University Hospital · unknown · Coronary Artery Disease · study chair
- Ph4NCT01267734 · Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis - SAfety & EffectiveneSS of Drug-ElUting Stents & Anti-platelet REgimenSeoul National University Hospital · unknown · Coronary Heart Disease · study chair
- Ph4NCT01120327 · A Pilot Study Exploring Efficacy and Safety of Amlodipine in the Stented Angina PatientsSeoul National University Hospital · completed · Coronary Artery Disease · principal investigator
- N/ANCT00960908 · Registry to Evaluate the Efficacy of Zotarolimus-Eluting StentSeoul National University Hospital · unknown · Coronary Artery Disease · study chair
- N/ANCT00960648 · Registry to Evaluate Efficacy of Xience/Promus Versus Cypher in Reducing Late Loss After StentingSeoul National University Hospital · completed · Coronary Artery Disease · study chair
- Ph4NCT00882388 · The Effect of Celecoxib on the Antiplatelet Effect of Aspirin and Clopidogrel in Normal VolunteersSeoul National University Hospital · completed · Healthy · principal investigator
- Ph4NCT00776828 · The Efficacy of CILostazol ON Ischemic Complications After DES ImplantationSeoul National University Hospital · completed · Coronary Artery Disease · principal investigator
- Ph3NCT00699543 · The Efficacies of The New Paclitaxel-Eluting CoroflexTM Please Stent in Percutaneous Coronary InterventionSeoul National University Hospital · unknown · Coronary Artery Disease · study chair
- Ph4NCT00698607 · Efficacy of Xience/Promus Versus Cypher in rEducing Late Loss After stENTingSeoul National University Hospital · completed · Coronary Artery Disease · study chair
- Ph2/Ph3NCT00501917 · MAGIC Cell-5-Combicytokine TrialSeoul National University Hospital · unknown · Acute Myocardial Infarction · principal investigator
- Ph4NCT00356954 · NASPI: N-Acetylcysteine vs. Ascorbic Acid for Prevention of Contrast Induced Nephropathy in Renal Insufficiency Undergoing Coronary CatheterizationSeoul National University Hospital · completed · Kidney Failure · study director
- Ph2NCT00307879 · Myocardial Regeneration and Angiogenesis in Myocardial Infarction With G-CSF and Intra-Coronary Stem Cell InfusionSeoul National University Hospital · terminated · Myocardial Infarction · principal investigator
- Ph2NCT00291629 · Myocardial Regeneration and Angiogenesis in Myocardial Infarction With G-CSF and Intra-Coronary Stem Cell Infusion-3-DESSeoul National University Hospital · completed · Myocardial Infarction · principal investigator
- Ph4NCT00259441 · PROMISS: Simvastatin Prevents the Contrast Induced Acute Renal Failure in Patients With Renal Insufficiency Undergoing Coronary AngiographySeoul National University Hospital · completed · Kidney Failure · study director
- Ph4NCT00247325 · RECOVER:Comparison of Renal Toxicity Between Visipaque(Iodixanol)and Hexabrix(Ioxaglate)in Renal Insufficiency Undergoing Coronary AngiographySeoul National University Hospital · completed · Kidney Failure · study director
Grants
NIH projects from RePORTER, fetched 2026-11-12 04:29 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 04:29 UTC. The ranking covers the 200 most relevant of 3853 PubMed records, and a shared surname and initials can bring in a namesake. All 3853 on PubMed
- Durvalumab or placebo plus gemcitabine and cisplatin in participants with advanced biliary tract cancer (TOPAZ-1): updated overall survival from a randomised phase 3 study.Lancet Gastroenterol Hepatol · 2024300 citationsRCR 38.0
- Gilteritinib as Post-Transplant Maintenance for AML With Internal Tandem Duplication Mutation of FLT3.J Clin Oncol · 2024220 citationsRCR 34.4
- 169 citationsRCR 16.1
- 86 citationsRCR 20.5
- 62 citationsRCR 15.7
- Safety and efficacy of inebilizumab for the treatment of neuromyelitis optica spectrum disorder: end-of-study results from the open-label period of the N-MOmentum trial.Lancet Neurol · 202460 citationsRCR 10.0
- Tolebrutinib versus Teriflunomide in Relapsing Multiple Sclerosis.N Engl J Med · 202560 citationsRCR 15.2
- Neoadjuvant Docetaxel, Oxaliplatin, and S-1 Plus Surgery and Adjuvant S-1 for Resectable Advanced Gastric Cancer: Updated Overall Survival Outcomes From Phase III PRODIGY.J Clin Oncol · 202459 citationsRCR 8.0
- Ertugliflozin for Functional Mitral Regurgitation Associated With Heart Failure: EFFORT Trial.Circulation · 202455 citationsRCR 8.3
- Effectiveness of Personalized Hippocampal Network-Targeted Stimulation in Alzheimer Disease: A Randomized Clinical Trial.JAMA Netw Open · 202453 citationsRCR 10.3